Rein Therapeutics Balance Sheet (2016-2025) | RNTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	19.28M	10.75M	7.60M	3.60M	7.45M	7.63M	4.84M	5.19M	7.78M	13.17M	12.07M	17.34M	12.04M	21.92M	17.65M	12.87M	7.43M	5.72M	4.05M	3.21M
Short-term Investments (Quarter)	44.07M	0.03M	44.63M	0.03M	30.63M	24.75M	0.03M	0.03M	0.03M	0.50M	0.03M	0.03M	0.03M	0.03M	0.03M
Cash & Current Investments (Quarter)	63.35M	10.77M	52.23M	3.62M	38.08M	32.38M	4.86M	5.22M	7.81M	13.67M	12.09M	17.36M	12.07M	21.94M	17.68M	12.87M	7.43M	5.72M	4.05M	3.21M
Prepaid Assets (Quarter)	0.95M	0.65M	2.17M	2.22M	1.89M	1.14M	1.55M	0.61M	0.36M	0.26M	0.70M	0.21M	0.55M	0.30M	0.76M	0.12M	0.86M	0.69M	0.13M	0.88M
Current Assets (Quarter)	64.32M	60.15M	54.42M	48.18M	39.99M	33.55M	27.05M	21.87M	17.11M	13.95M	12.79M	18.27M	12.76M	23.16M	18.68M	13.66M	8.33M	6.60M	5.17M	4.33M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.10M	0.15M	0.14M	0.13M	0.11M	0.10M	0.08M	0.07M	0.05M	0.04M	0.03M	0.02M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M
Goodwill (Quarter)												6.33M	6.33M	6.33M	6.33M	6.33M	6.33M	6.33M	6.33M	6.33M
Intangibles (Quarter)												79.20M	79.20M	79.20M	79.20M	42.20M	42.20M	42.20M	42.20M	13.50M
Goodwill & Intangibles (Quarter)												85.53M	85.53M	85.53M	85.53M	48.53M	48.53M	48.53M	48.53M	19.83M
Other Non-Current Assets (Quarter)	0.02M	0.02M	0.02M	0.03M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.03M	2.19M	0.05M	0.71M	0.00M	0.00M	0.77M	2.35M	0.00M	0.00M
Non-Current Assets (Quarter)	0.35M	0.38M	0.34M	0.30M	0.26M	0.22M	0.18M	0.13M	0.05M	0.04M	0.03M	87.74M	86.43M	86.24M	85.53M	48.53M	49.30M	50.88M	48.53M	19.83M
Assets (Quarter)	64.67M	60.53M	54.77M	48.48M	40.26M	33.77M	27.23M	22.01M	17.16M	13.99M	12.82M	106.01M	99.19M	109.40M	104.22M	62.19M	57.63M	57.48M	53.71M	24.16M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.56M	1.02M	1.03M	1.21M	1.02M	1.74M	0.94M	1.72M	0.46M	0.14M	0.48M	1.19M	2.16M	0.78M	1.08M	0.91M	1.15M	6.03M	4.12M	3.98M
Payables (Quarter)	0.56M	1.02M	1.03M	1.21M	1.02M	1.74M	0.94M	1.72M	0.46M	0.14M	0.48M	1.19M	2.16M	0.78M	1.08M	0.91M	1.15M	6.03M	4.12M	3.98M
Accumulated Expenses (Quarter)	0.43M	0.74M	3.43M	1.18M	0.54M	3.31M	3.52M	1.63M	0.14M	1.06M	0.10M	3.15M	2.38M	4.16M	1.45M	4.84M	4.83M	0.64M	0.71M	0.94M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)	0.33M
Current Leases (Quarter)	0.09M	0.09M	0.09M	0.09M	0.13M	0.10M	0.07M	0.03M				0.05M
Total Current Liabilities (Quarter)	3.07M	4.27M	4.56M	4.51M	4.15M	5.15M	4.54M	3.38M	2.88M	1.20M	1.62M	4.38M	4.53M	4.94M	5.66M	5.75M	5.98M	7.69M	5.74M	6.18M
Non-Current Liabilities
Non-Current Debt (Quarter)	0.06M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)												91.41M	46.58M	45.01M	45.01M	45.01M	45.01M	45.01M	45.01M	45.01M
Minority Interest (Quarter)
Non-Current Deferred Tax Liability (Quarter)												3.33M	3.33M	3.33M	3.33M	1.77M	1.77M	1.77M	1.77M	1.06M
Operating Leases (Quarter)	0.12M	0.13M	0.10M	0.07M	0.22M	0.22M	0.22M
Other Non-Current Liabilities (Quarter)														0.12M		0.28M
Total Non-Current Liabilities (Quarter)														8.26M		7.52M	7.75M	9.47M	7.52M	7.24M
Total Liabilities (Quarter)	3.25M	4.40M	4.66M	4.58M	4.15M	5.15M	4.54M	3.38M	2.88M	1.20M	1.62M	7.71M	7.86M	8.38M	8.98M	7.80M	7.75M	9.47M	7.52M	7.24M
Shareholder's Equity
Total Debt (Quarter)	0.38M
Common Equity (Quarter)	61.42M	56.13M	50.11M	43.90M	36.11M	28.62M	22.70M	18.62M	14.27M	12.79M	11.20M	98.30M	91.33M	101.02M	95.23M	54.39M	49.88M	48.01M	46.19M	16.92M
Shareholder's Equity (Quarter)	61.42M	56.13M	50.11M	43.90M	36.11M	28.62M	22.70M	18.62M	14.27M	12.79M	11.20M	98.30M	91.33M	101.02M	95.23M	54.39M	49.88M	48.01M	46.19M	16.92M
Liabilities and Shareholders Equity (Quarter)	64.67M	60.53M	54.77M	48.48M	40.26M	33.77M	27.23M	22.01M	17.16M	13.99M	12.82M	106.01M	99.19M	109.40M	104.22M	62.19M	57.63M	57.48M	53.71M	24.16M
Retained Earnings (Quarter)	-226.27M	-231.95M	-238.66M	-0.01M	-0.07M	-0.10M	-268.24M	-272.79M	-0.01M	-279.35M	-281.18M	-288.52M	-0.06M	-0.02M	-310.42M	-351.40M	-356.90M	-0.04M	-369.30M	-401.27M
Treasury Shares (Quarter)	0.25M

Research Tools

Rein Therapeutics Balance Sheet (2016-2025) | RNTX

Create an account

Sign In

Reset Password